Genoil Inc.

What they do

Genoil holds patents and technology rights in the oil and gas field services sector and is attempting to commercialize those technologies. According to the 20-F, the company has not attained commercially viable operations from its various patents and technology rights. It has not yet generated significant recurring revenues from operations and has historically financed its operations primarily through the issuance of equity securities. Its principal executive offices are in Calgary, Alberta, and its common shares are quoted on the OTC Markets Quotation System.

Revenue drivers

• Patents and technology rights — The company describes itself as holding various patents and technology rights but states it has not attained commercially viable operations from them; reportable revenue was $0.00 in each year from 2020 through 2024.
• Commercialization of technologies — Management states that continuing as a going concern depends on commercializing its technologies, achieving profitable operations and obtaining necessary financing; no commercialized product revenue is disclosed in the provided excerpts.
• Equity financing — The company states it has historically financed operations primarily through the issuance of equity securities rather than through product or service sales, with common shares outstanding rising from 1,913,137,429 at December 31, 2023 to 2,018,347,429 at December 31, 2025.

Recent performance

Annual revenue was $0.00 in each of 2020, 2021, 2022, 2023 and 2024. Net loss was $4.5M in 2020, $2.5M in 2021, $3.6M in 2022, $4.3M in 2023 and $2.1M in 2024, narrowing in the most recent year. Operating cash flow was negative each year, from $-330,067 in 2020 to $-606,427 in 2024. At December 31, 2024, total assets were $133,614, total liabilities were $458,489, cash and equivalents were $12,036, and shareholder equity was negative $324,875.

Strategy

Management states that the ability of the Company to continue as a going concern depends on commercializing its technologies, achieving profitable operations and obtaining the necessary financing to develop those technologies further. The company says it will continue to review the prospects of raising additional debt and equity financing to support operations until operations become self-sustaining, to fund research and development activities and to ensure realization of assets and discharge of liabilities. Management states it is expending its best efforts to achieve these plans but provides no assurance that such activity will generate sufficient funds for future operations. The filing also indicates the company expects to rely on its historical ability and ongoing expectation to raise additional capital through equity financings to fund planned operations and meet obligations as they become due.

Risks

• Going concern — The company states that it has not attained commercially viable operations from its patents and technology rights and that its ability to continue as a going concern depends on commercializing technologies, achieving profitable operations and obtaining necessary financing.
• No revenue and recurring losses — Annual revenue was $0.00 in each year from 2020 through 2024, and the company has incurred operating losses and negative cash flows from operations since inception.
• Negative operating cash flow — Operating cash flow was negative in every year from 2020 ($-330,067) through 2024 ($-606,427), requiring external funding to sustain operations.
• Negative shareholder equity and thin cash — At December 31, 2024, shareholder equity was negative $324,875, total liabilities of $458,489 exceeded total assets of $133,614, and cash and equivalents were only $12,036.

Outlook

Management says it has evaluated expected cash requirements for the twelve-month period following the issuance date of the financial statements and believes existing cash resources, together with its historical ability and ongoing expectation to raise additional capital through equity financings, will be sufficient to fund planned operations and meet obligations as they become due. The company states it will continue to review the prospects of raising additional debt and equity financing until operations become self-sustaining, to fund research and development and to ensure realization of assets and discharge of liabilities. Management cautions that the outcome of these matters cannot be predicted at this time and that there is no assurance any such activity will generate sufficient funds for future operations.